Loading clinical trials...
Loading clinical trials...
A Phase I Study of Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer
Conditions
Interventions
taxol plus everolimus
Locations
1
South Korea
Samsung Medical Center
Seoul, South Korea
Start Date
December 1, 2009
Primary Completion Date
May 1, 2012
Completion Date
April 1, 2013
Last Updated
May 30, 2013
NCT06305754
NCT05692635
NCT07485114
NCT07190248
NCT06066138
NCT07100080
Lead Sponsor
Samsung Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions